These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21503766)

  • 1. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Straub BK; Schirmacher P; Kovalszky I; Lotz G; Kiss A; Schaff Z
    Virchows Arch; 2011 Jun; 458(6):679-88. PubMed ID: 21503766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.
    Ono Y; Hiratsuka Y; Murata M; Takasawa A; Fukuda R; Nojima M; Tanaka S; Osanai M; Hirata K; Sawada N
    Virchows Arch; 2016 Oct; 469(4):417-26. PubMed ID: 27444172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricellulin expression and its prognostic significance in primary liver carcinomas.
    Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A
    Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
    Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
    Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrolamellar carcinomas are positive for CD68.
    Ross HM; Daniel HD; Vivekanandan P; Kannangai R; Yeh MM; Wu TT; Makhlouf HR; Torbenson M
    Mod Pathol; 2011 Mar; 24(3):390-5. PubMed ID: 21113139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.
    Shafizadeh N; Ferrell LD; Kakar S
    Mod Pathol; 2008 Aug; 21(8):1011-8. PubMed ID: 18536657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.
    Lódi C; Szabó E; Holczbauer A; Batmunkh E; Szíjártó A; Kupcsulik P; Kovalszky I; Paku S; Illyés G; Kiss A; Schaff Z
    Mod Pathol; 2006 Mar; 19(3):460-9. PubMed ID: 16439986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
    Ward SC; Huang J; Tickoo SK; Thung SN; Ladanyi M; Klimstra DS
    Mod Pathol; 2010 Sep; 23(9):1180-90. PubMed ID: 20495535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
    Zhou S; Parham DM; Yung E; Pattengale P; Wang L
    Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver.
    Van Eyken P; Sciot R; Brock P; Casteels-Van Daele M; Ramaekers FC; Desmet VJ
    Histopathology; 1990 Aug; 17(2):101-7. PubMed ID: 1699871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas.
    Vivekanandan P; Micchelli ST; Torbenson M
    Hum Pathol; 2009 Mar; 40(3):293-9. PubMed ID: 18973922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
    Abdul-Al HM; Wang G; Makhlouf HR; Goodman ZD
    Int J Surg Pathol; 2010 Oct; 18(5):313-8. PubMed ID: 20444731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma].
    Yip YC; Wang FH; Vong HT; Zhang M; Wen JM
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):626-9. PubMed ID: 22177248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
    Ward SC; Waxman S
    Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Törzsök P; Kovalszky I; Barbai T; Rásó E; Lotz G; Schaff Z; Kiss A
    Pathol Oncol Res; 2013 Jan; 19(1):63-70. PubMed ID: 22872444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.